OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AMBR52

Ambar Protein Industries Ltd

Food ProcessingVerified

Ambar Protein Industries Ltd has a debt-to-equity ratio of 1.02, indicating a relatively balanced capital structure, though its liquidity position is assessed as medium risk. The company's cash and equivalents amount to INR 10.75 million, while its long-term debt stands at INR 255.02 million, resulting in a negative net cash position after subtracting total debt. The operating cash flow of INR 69.66 million suggests some capacity to service debt, but the current ratio of 1.21 implies limited short-term liquidity cushion. Profitability metrics are weak, with a return on equity of -1.81% and a return on assets of -0.74%, both significantly below the industry median for Food Processing. The company reported a net loss of INR 4.54 million and an operating loss of INR 10.94 million in the latest period, indicating operational inefficiencies or pricing pressures. Gross profit of INR 41.70 million is also low relative to revenue of INR 895.05 million, suggesting margin compression or high cost of goods sold. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional demand fluctuations and supply chain disruptions. The absence of segment or geographic breakdown in the financial snapshot limits visibility into potential growth or risk areas. Growth prospects are constrained, with no disclosed revenue growth in the latest period and no forward-looking guidance provided. The company's capital expenditure of INR 6.88 million is minimal, suggesting limited investment in capacity expansion or innovation. The outlook for the current fiscal year does not indicate a material improvement in revenue or profitability. Risk factors include the company's negative net cash position and weak profitability, which could lead to liquidity stress if operating cash flow declines. The risk assessment flags net cash as negative after subtracting total debt, and while dilution risk is currently low, the company may face pressure to raise capital if losses persist. No recent dilutive events are disclosed, and the number of shares outstanding remains unchanged between basic and diluted shares. No recent filings or transcripts are available to provide insight into management commentary or strategic direction. The absence of disclosed events or earnings calls limits the ability to assess management's response to operational challenges or market conditions.

30-day price · AMBR+41.60 (+26.0%)
Low$155.00High$210.00Close$201.60As of15 May, 00:00 UTC
Profile
CompanyAmbar Protein Industries Ltd
TickerAMBR.BO
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Ambar Protein Industries Ltd has a debt-to-equity ratio of 1.02, indicating a relatively balanced capital structure, though its liquidity position is assessed as medium risk. The company's cash and equivalents amount to INR 10.75 million, while its long-term debt stands at INR 255.02 million, resulting in a negative net cash position after subtracting total debt. The operating cash flow of INR 69.66 million suggests some capacity to service debt, but the current ratio of 1.21 implies limited short-term liquidity cushion. Profitability metrics are weak, with a return on equity of -1.81% and a return on assets of -0.74%, both significantly below the industry median for Food Processing. The company reported a net loss of INR 4.54 million and an operating loss of INR 10.94 million in the latest period, indicating operational inefficiencies or pricing pressures. Gross profit of INR 41.70 million is also low relative to revenue of INR 895.05 million, suggesting margin compression or high cost of goods sold. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional demand fluctuations and supply chain disruptions. The absence of segment or geographic breakdown in the financial snapshot limits visibility into potential growth or risk areas. Growth prospects are constrained, with no disclosed revenue growth in the latest period and no forward-looking guidance provided. The company's capital expenditure of INR 6.88 million is minimal, suggesting limited investment in capacity expansion or innovation. The outlook for the current fiscal year does not indicate a material improvement in revenue or profitability. Risk factors include the company's negative net cash position and weak profitability, which could lead to liquidity stress if operating cash flow declines. The risk assessment flags net cash as negative after subtracting total debt, and while dilution risk is currently low, the company may face pressure to raise capital if losses persist. No recent dilutive events are disclosed, and the number of shares outstanding remains unchanged between basic and diluted shares. No recent filings or transcripts are available to provide insight into management commentary or strategic direction. The absence of disclosed events or earnings calls limits the ability to assess management's response to operational challenges or market conditions.
Key takeaways
  • The company is operating at a loss with weak profitability metrics, including a negative return on equity and assets.
  • Liquidity is a concern due to a negative net cash position and a current ratio of 1.21.
  • Revenue is concentrated in a single segment, with no geographic diversification disclosed.
  • Growth is limited, with minimal capital expenditure and no forward-looking guidance provided.
  • The risk of dilution is currently low, but the company may need to raise capital if losses continue.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$895.1M
Gross profit$41.7M
Operating income-$10.9M
Net income-$4.5M
R&D
SG&A
D&A
SBC
Operating cash flow$69.7M
CapEx-$6.9M
Free cash flow
Total assets$613.8M
Total liabilities$363.1M
Total equity$250.7M
Cash & equivalents$10.8M
Long-term debt$255.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$3.13B$66.3M$34.5M$38.1M
FY-3$3.40B$81.9M$44.5M$50.5M
FY-2$3.45B$59.9M$28.1M$33.5M
FY-1$3.37B$59.1M$31.5M$37.7M
FY0$4.22B$144.6M$96.5M$98.2M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$502.3M$146.5M$10.6M
FY-3$641.4M$191.0M$9.0M
FY-2$622.9M$219.3M$11.3M
FY-1$613.8M$250.7M$10.8M
FY0$705.0M$347.3M$11.3M
PeriodOCFCapExFCFSBC
FY-4$11.0M-$8.4M$38.1M
FY-3-$25.3M-$6.8M$50.5M
FY-2$61.8M-$7.4M$33.5M
FY-1$69.7M-$6.9M$37.7M
FY0$21.7M-$11.5M$98.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$895.1M-$10.9M-$4.5M
FQ-6$930.4M$26.3M$17.2M
FQ-5$889.5M$39.0M$26.9M
FQ-4$1.12B$43.6M$28.2M
FQ-3$1.28B$35.7M$24.8M
FQ-2$1.17B$18.1M$7.5M
FQ-1$1.12B$21.6M$20.0M
FQ0$1.25B$29.0M$18.1M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$613.8M$250.7M$10.8M
FQ-6
FQ-5$617.2M$294.8M$6.5M
FQ-4
FQ-3$705.0M$347.3M$11.3M
FQ-2
FQ-1$703.4M$374.8M$3.9M
FQ0
PeriodOCFCapExFCFSBC
FQ-7$69.7M-$6.9M
FQ-6
FQ-5$17.9M-$957.0k
FQ-4
FQ-3$21.7M-$11.5M
FQ-2
FQ-1$32.5M-$2.8M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$250.7M
Net cash-$244.3M
Current ratio1.2
Debt/Equity1.0
ROA-0.7%
ROE-1.8%
Cash conversion-15.3%
CapEx/Revenue-0.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 1040 companies
MetricAMBRActivity
Op margin-1.2%5.6% medp25 2.1% · p75 11.2%bottom quartile
Net margin-0.5%3.9% medp25 0.5% · p75 8.5%bottom quartile
Gross margin4.7%23.3% medp25 14.8% · p75 32.6%bottom quartile
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-0.8%-4.1% medp25 -8.9% · p75 -1.9%top quartile
Debt / equity102.0%37.6% medp25 7.2% · p75 84.5%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 02:06 UTC#224f415b
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 08:37 UTCJob: 8a575f99